The most common form of TTP is immune-mediated TTP (iTTP), involving autoantibodies against ADAMTS-13, which rapidly clear the enzyme from the circulation and inhibit its activity by preventing binding to its substrate VWF [190]. The gene discussed is VWF; the disease is thrombotic thrombocytopenic purpura.